Browsing: EU HTA Regulation

The EU Health Technology Assessment (HTA) Regulation is now a reality, ushering in a new chapter for pharmaceutical market access across Europe. This article discusses the challenges and opportunities presented by the new regulation.

EUCOPE’s Alexander Natz highlights the value of early engagement with national agencies for companies unable to participate in joint scientific consultations under the EU Health Technology Assessment Regulation.